English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 29490/55136 (53%)
造訪人次 : 1994341      線上人數 : 424
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於CMUR管理 到手機版
    請使用永久網址來引用或連結此文件: http://ir.cmu.edu.tw/ir/handle/310903500/712


    題名: 下咽癌患者以手術及以化療合併放療為初始治療之存活率比較;The Comparison of Survival Rate Between Surgery and Chemoradiation Therapy as Initial Treatment in Hypopharyngeal Cancer
    作者: 林芳永;Fang-Yung Lin
    貢獻者: 中國醫藥大學:臨床醫學研究所碩士班
    關鍵詞: 下咽癌;治療效果;存活率;手術;化療合併放療;hypopharyngeal cancer;treatment outcome;survival rate;surgery;chemoradiotherapy
    日期: 2008-07-16
    上傳時間: 2009-08-12 14:23:39 (UTC+8)
    摘要: 研究目的
    下咽癌是頭頸部癌症中預後最差的癌症之一,其最適當的治療方式至目前為止並無定論。下咽癌傳統的治療方式為手術,必要時加上術後放射線治療。但由於大多數患者被診斷時已是較嚴重的第三、第四期,手術常為全喉切除手術,失去喉嚨的恐懼使得不少患者不願接受手術治療。近年來由於放射線及化學治療的進步,下咽癌患者已可選用化療合併放療這種「器官保存」療法做為初始治療。本文旨在比較手術及化療合併放療這兩大治療方式治療下咽癌之存活率,以作為日後醫界治療下咽癌之參考。

    研究方法
    本研究以台中榮民總醫院於1996年1月1日至2006年2月28日間診斷出罹患下咽癌且接受治療之209位患者為研究對象,做一回溯性的研究。209位患者中,接受手術為初始治療的患者有123位,接受化療合併放療為初始治療的患者有86位。

    研究結果
    整體而言,台中榮總治療下咽癌的五年存活率:stage I: 100%, stage II: 67.34%,stage III: 59.12,stage IVa+IVb:33.40%。手術組的五年存活率為48.3%,化療合併放療組的五年存活率為34.6%,兩組之存活率在統計上具有顯著差異
    (p=0.0003<0.05)。而手術組各個stage之五年存活率為:stage I: 100%,stage III: 76.4%,stage IVa+IVb:38.00%;stage II之三年存活率為:30%。化療合併放療組各個stage之五年存活率為:stage II: 100%,stage III: 30.0%,stage IVa+IVb: 28.40%。

    研究結論
    本研究結果顯示接受手術治療的下咽癌患者其存活率顯著優於接受化療合併放療的患者。針對本文研究結果,我們建議末期下咽癌的患者治療時應先考慮接受手術治療,而非為了保存器官選擇化療合併放療。當然,我們也期待更多有關下咽癌的治療結果文獻能發表出來,以確認下咽癌最適切的治療方式。

    Objective
    The prognosis of hypopharyngeal cancer is one of the worst among head and neck cancers. However, the most appropriate treatment for hypopharyngeal cancer has not yet been determined. The traditional treatment for hypopharyngeal cancer is operation plus radiotherapy, if the latter is needed. Many patients are not willing to receive operation because the operation for hypopharyngeal cancer usually comprises total laryngectomy due to the late stage when the illness is diagnosed. In recent years, with the improvement of radiotherapy and chemotherapy, hypopharyngeal cancer patient can receive chemoradiation as initial treatment (also known as organ preservation therapy). The purpose of this research is to compare the survival rate between surgery and chemoradiation therapy and hopefully to offer some suggestions in the treatment of hypopharyngeal cancer in the future.

    Methods
    We retrospectively analyzed 209 hypopharyngeal cancer patients whose diseases were diagnosed and treated in Taichung Veteran General Hospital from January 1, 1996 to February 28, 2006. Among them, 123 patients received operation as initial treatment and 86 patients received chemoradiation therapy as initial treatment.

    Results
    Overall, the five year survival rates in the treatment of hypopharyngeal cancer in Taichung Veteran General Hospital were: stage I: 100%, stage II: 67.34%,stage III: 59.12,stage IVa+IVb:33.40%. The five year survival rate was 48.3% for patients who received surgey as initial treatment and 34.6% for patients who received chemoradiation therapy as initial treatment. The difference between survival rates of the two treatment groups was statistically significant(p=0.0003<0.05). The five year survival rates of the surgery first group in each stage were: stage I: 100%,stage III: 76.4%,stage IVa+IVb:38.00%. The three year survival rate of stage II of the surgery first group was:30%. The five year survival rates of the chemoradiation first group in each stage were: stage II: 100%,stage III: 30.0%,stage IVa+IVb:28.40%.

    Conclusion
    The result of this research shows that in treating hypopharyngeal cancer, the patients who received surgery as initial treatment had significantly higher survival rate than those who received chemoradiation therapy as initial treatment. According to this result, we suggest that advanced stage hypopharyngeal cancer patients should choose surgery as initial treatment rather than chemoradiation therapy as initial treatment just to preserve the organ. We also hope that more literature about the treatment of hypopharyngeal cancer can be reported, so that the most appropriate way to treat this dangerous cancer can be secured.
    顯示於類別:[臨床醫學研究所] 博碩士論文

    文件中的檔案:

    檔案 大小格式瀏覽次數
    index.html0KbHTML27檢視/開啟


    在CMUR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

     


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋